| Company | Share, % |
|---|---|
| Ambrx Biopharma Inc. | 17.78 |
| Chemomab Therapeutics Ltd. | 15.66 |
| Immuneering Corporation | 14.36 |
| Harpoon Therapeutics, Inc. | 13.87 |
| Biomea Fusion, Inc. | 9.93 |
 VYNE Therapeutics Inc.
|
9.89 |
| Longboard Pharmaceuticals, Inc. | 7 |
 Tarsus Pharmaceuticals, Inc.
|
6.49 |
 ALX Oncology Holdings Inc.
|
6.27 |
 Praxis Precision Medicines, Inc.
|
4.78 |
| Enliven Therapeutics, Inc. | 4.71 |
| Tango Therapeutics, Inc. | 4.65 |
 Olema Pharmaceuticals, Inc.
|
4.39 |
| Aerovate Therapeutics, Inc. | 4.35 |
| VectivBio Holding AG | 4.04 |
 Alpine Immune Sciences, Inc.
|
3.89 |
 Prometheus Biosciences, Inc.
|
3.46 |
| Pharvaris B.V. | 3.28 |
| Arcellx, Inc. | 3.22 |
| BioAtla, Inc. | 2.46 |
| Talaris Therapeutics, Inc. | 2.14 |
 Autolus Therapeutics plc
|
2.05 |
 BridgeBio Pharma, Inc.
|
1.9 |
| GH Research PLC | 1.14 |
